BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28561249)

  • 1. Interstitial Lung Disease in Women of Child-Bearing Age.
    Mylvaganam R; Dua S; Nelson-Piercy C; Mathur A
    Semin Respir Crit Care Med; 2017 Apr; 38(2):185-190. PubMed ID: 28561249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for the treatment of connective tissue disease-associated interstitial lung disease.
    Chartrand S; Swigris JJ; Peykova L; Fischer A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):296-304. PubMed ID: 26847096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapies for interstitial lung disease: past, present and future.
    Kim R; Meyer KC
    Ther Adv Respir Dis; 2008 Oct; 2(5):319-38. PubMed ID: 19124380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial lung disease in systemic sclerosis.
    Bussone G; Mouthon L
    Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial lung disease: causes, treatment, and prevention.
    Perez RL
    Ethn Dis; 2005; 15(2 Suppl 2):S45-8. PubMed ID: 15822838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial lung disease in systemic sclerosis: current and future treatment.
    Giacomelli R; Liakouli V; Berardicurti O; Ruscitti P; Di Benedetto P; Carubbi F; Guggino G; Di Bartolomeo S; Ciccia F; Triolo G; Cipriani P
    Rheumatol Int; 2017 Jun; 37(6):853-863. PubMed ID: 28063071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interstitial lung diseases].
    Mazzoccoli G; Carughi S; De Cata A; Giuliani A; Masciale N; La Viola M; Puzzolante F; Balzanelli M
    Recenti Prog Med; 2003 May; 94(5):227-37. PubMed ID: 12723502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial lung disease in connective tissue disorders.
    Fischer A; du Bois R
    Lancet; 2012 Aug; 380(9842):689-98. PubMed ID: 22901890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
    Cavagna L; Caporali R; Abdì-Alì L; Dore R; Meloni F; Montecucco C
    J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
    Owen C; Ngian GS; Elford K; Moore O; Stevens W; Nikpour M; Rabusa C; Proudman S; Roddy J; Zochling J; Hill C; Sturgess A; Tymms K; Youssef P; Sahhar J
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):170-176. PubMed ID: 27049330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease.
    Ryu JH; Myers JL; Capizzi SA; Douglas WW; Vassallo R; Decker PA
    Chest; 2005 Jan; 127(1):178-84. PubMed ID: 15653981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy Considerations for Patients With Interstitial Lung Disease.
    Grant-Orser A; Metcalfe A; Pope JE; Johannson KA
    Chest; 2022 Nov; 162(5):1093-1105. PubMed ID: 35779609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial lung disease in children.
    Bokulic RE; Hilman BC
    Pediatr Clin North Am; 1994 Jun; 41(3):543-67. PubMed ID: 8196991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
    Oldham JM; Lee C; Valenzi E; Witt LJ; Adegunsoye A; Hsu S; Chen L; Montner S; Chung JH; Noth I; Vij R; Strek ME
    Respir Med; 2016 Dec; 121():117-122. PubMed ID: 27888985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy.
    Sasano H; Hagiwara E; Kitamura H; Enomoto Y; Matsuo N; Baba T; Iso S; Okudela K; Iwasawa T; Sato S; Suzuki Y; Takemura T; Ogura T
    BMC Pulm Med; 2016 Dec; 16(1):168. PubMed ID: 27903248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
    Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
    Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung diseases in children.
    Clement A; Nathan N; Epaud R; Fauroux B; Corvol H
    Orphanet J Rare Dis; 2010 Aug; 5():22. PubMed ID: 20727133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.
    Tan A; Denton CP; Mikhailidis DP; Seifalian AM
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S66-74. PubMed ID: 21586221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease.
    Kwon HM; Kang EH; Park JK; Go DJ; Lee EY; Song YW; Lee HJ; Lee EB
    Rheumatology (Oxford); 2015 Oct; 54(10):1792-6. PubMed ID: 25972389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.